Rockefeller Capital Management’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.3K Hold
11,065
– – ﹤0.01% 3674
2026
Q2
$38.6K Sell
11,065
-2,700
-20% -$8.7K ﹤0.01% 3481
2026
Q1
$39.6K Buy
13,765
+4,177
+44% +$16.5K ﹤0.01% 3396
2025
Q4
$39K Buy
9,588
+4,088
+74% +$18.3K ﹤0.01% 3189
2025
Q3
$19.5K Buy
+5,500
New +$19.9K ﹤0.01% 3368

Other funds holding SANA

Rockefeller Capital Management's SANA Position: Q3 2026 in Review

Rockefeller Capital Management held its Sana Biotechnology (SANA) position steady in Q3 2026 at 11,065 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3674.

Rockefeller Capital Management first reported a position in SANA in Q3 2025 and has held it in 5 quarters since. The position peaked at $39.6K in Q1 2026. 203 funds tracked by Wall St. Rank hold SANA as of Q3 2026.

  • Rockefeller Capital Management held 11,065 shares of Sana Biotechnology worth $32.3K as of Q3 2026.
  • Rockefeller Capital Management left its Sana Biotechnology share count unchanged in Q3 2026.
  • Sana Biotechnology made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #3674 holding.
  • Rockefeller Capital Management first reported a position in Sana Biotechnology in Q3 2025 and has held it in 5 quarters since.
  • Rockefeller Capital Management's Sana Biotechnology position peaked at $39.6K in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.